The Efficacy of Prophylactic Antibiotic Administration During Breast Cancer Surgery in Overweight Patients.
Status:
Completed
Trial end date:
2010-05-01
Target enrollment:
Participant gender:
Summary
This is a single center trial to compare the rate of surgical site infection (SSI) in normal
(BMI equal to or less than 25; Control Group)) and overweight (BMI over 25) women who are
undergoing breast cancer surgery. The overweight patients are further randomized into two
groups; in one group patients receive prophylactic antibiotics (ampicillin/sulbactam;
Prophylaxis Group), in the other they do not (No Prophylaxis Group).